P Olliaro

981 total citations
30 papers, 618 citations indexed

About

P Olliaro is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, P Olliaro has authored 30 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 9 papers in Infectious Diseases and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in P Olliaro's work include Tuberculosis Research and Epidemiology (7 papers), Mycobacterium research and diagnosis (6 papers) and Malaria Research and Control (5 papers). P Olliaro is often cited by papers focused on Tuberculosis Research and Epidemiology (7 papers), Mycobacterium research and diagnosis (6 papers) and Malaria Research and Control (5 papers). P Olliaro collaborates with scholars based in Italy, France and United Kingdom. P Olliaro's co-authors include R.A. Neal, Simon L. Croft, Francesco Castelli, Daniela Elena Quacci, Silvia Sacchi, Baohong Ji, J Grosset, C. Truffot-Pernot, Giorgio Roscigno and Richard O’Brien and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

P Olliaro

30 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Olliaro Italy 11 285 228 202 87 74 30 618
R. N. MSHANA Ethiopia 15 345 1.2× 377 1.7× 157 0.8× 125 1.4× 100 1.4× 24 749
B Rowan-Kelly Australia 19 244 0.9× 170 0.7× 155 0.8× 19 0.2× 271 3.7× 30 869
Timothy J. Holzer United States 12 366 1.3× 235 1.0× 80 0.4× 84 1.0× 140 1.9× 23 716
Paulo R. Z. Antas Brazil 19 494 1.7× 370 1.6× 229 1.1× 138 1.6× 126 1.7× 41 883
B. R. Andersen United States 15 349 1.2× 350 1.5× 55 0.3× 83 1.0× 192 2.6× 38 858
G. Tovey United Kingdom 14 360 1.3× 121 0.5× 134 0.7× 18 0.2× 59 0.8× 29 688
Valerie J. F. Quesniaux France 8 396 1.4× 341 1.5× 103 0.5× 62 0.7× 117 1.6× 8 882
Parvapan Bhattarakosol Thailand 15 294 1.0× 147 0.6× 90 0.4× 61 0.7× 175 2.4× 76 713
HN Madhavan India 14 219 0.8× 155 0.7× 86 0.4× 31 0.4× 36 0.5× 39 526
Masao Okumoto United States 19 307 1.1× 68 0.3× 353 1.7× 17 0.2× 130 1.8× 81 1.0k

Countries citing papers authored by P Olliaro

Since Specialization
Citations

This map shows the geographic impact of P Olliaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Olliaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Olliaro more than expected).

Fields of papers citing papers by P Olliaro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Olliaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Olliaro. The network helps show where P Olliaro may publish in the future.

Co-authorship network of co-authors of P Olliaro

This figure shows the co-authorship network connecting the top 25 collaborators of P Olliaro. A scholar is included among the top collaborators of P Olliaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Olliaro. P Olliaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sundar, Shyam, P Olliaro, Jaya Chakravarty, et al.. (2007). Combination liposomal amphotericin B (AmBisome (R), AmB) and miltefosine (MF) for the treatment of visceral leishmaniasis (VL) in northern Bihar, India. American Journal of Tropical Medicine and Hygiene. 77. 109–109. 1 indexed citations
2.
Matteelli, Alberto, P Olliaro, Liana Signorini, et al.. (1999). Tolerability of twice-weekly rifabutin-isoniazid combinations versus daily isoniazid for latent tuberculosis in HIV-infected subjects: a pilot study.. PubMed. 3(11). 1043–6. 20 indexed citations
3.
Olliaro, P, et al.. (1998). Safety of artemisinin and its derivatives. A review of published and unpublished clinical trials.. PubMed. 58(3 Suppl). 50–3. 108 indexed citations
4.
Olliaro, P & Francesco Castelli. (1997). Plasmodium falciparum: an electronmicroscopy study of caveolae and trafficking between the parasite and the extracellular medium. International Journal for Parasitology. 27(9). 1007–1012. 15 indexed citations
5.
Olliaro, P, et al.. (1996). Efficacy and Safety of Rifabutin in the Treatment of Patients With Newly Diagnosed Pulmonary Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 154(5). 1462–1467. 70 indexed citations
6.
Lee, Chien‐Nan, et al.. (1996). Rifabutin as Salvage Therapy for Cases of Chronic Multidrug-Resistant Pulmonary Tuberculosis in Taiwan. Journal of Chemotherapy. 8(2). 137–143. 10 indexed citations
7.
Dautzenberg, Bertrand, P Olliaro, Roberto Esposito, et al.. (1996). Rifabutin Versus Placebo in Combination with Three Drugs in the Treatment of Nontuberculous Mycobacterial Infection in Patients with AIDS. Clinical Infectious Diseases. 22(4). 705–708. 5 indexed citations
8.
Neal, R.A., et al.. (1995). The sensitivity of Leishmania species to aminosidine. Journal of Antimicrobial Chemotherapy. 35(5). 577–584. 78 indexed citations
9.
Olliaro, P, et al.. (1994). Prevalence of chlamydial antibody in pregnancy. European Journal of Epidemiology. 10(1). 47–50. 1 indexed citations
10.
Olliaro, P, et al.. (1994). In-vitro and in-vivo activity of rifabutin against Toxoplasma gondii. Journal of Antimicrobial Chemotherapy. 34(5). 649–657. 10 indexed citations
11.
12.
Olliaro, P, et al.. (1994). Chlamydia trachomatis infection in "sine causa" recurrent abortion.. PubMed. 70(1-2). 467–70. 1 indexed citations
13.
Jabés, Daniela, et al.. (1994). Effectiveness of rifabutin alone or in combination with isoniazid in preventive therapy of mouse tuberculosis. Antimicrobial Agents and Chemotherapy. 38(10). 2346–2350. 19 indexed citations
14.
Ji, Baohong, C. Truffot-Pernot, Christian Lacroix, et al.. (1993). Effectiveness of Rifampin, Rifabutin, and Rifapentine for Preventive Therapy of Tuberculosis in Mice. American Review of Respiratory Disease. 148(6_pt_1). 1541–1546. 91 indexed citations
15.
Olliaro, P, et al.. (1993). Toxoplasma gondii virulence: changing pattern under different maintenance conditions.. PubMed. 35(1-3). 17–9. 4 indexed citations
16.
Gorini, Giovanna, et al.. (1991). Evaluation of Diagnostic Procedures in Chamydial Eye Infection. Ophthalmologica. 203(3). 114–117. 2 indexed citations
17.
Olliaro, P, et al.. (1990). Chlamydia trachomatis infection in primary unexplained infertility. European Journal of Epidemiology. 6(3). 335–338. 10 indexed citations
18.
Olliaro, P, Francesco Castelli, Silvio Caligaris, Pierre Druilhe, & Giampiero Carosi. (1989). Ultrastructure of Plasmodium falciparum "in vitro". II. Morphological patterns of different quinolines effects.. PubMed. 12(1). 15–28. 14 indexed citations
19.
Olliaro, P, et al.. (1984). In vitro Fibroblast and Dermis Fibroblast Activation by Laser Irradiation at Low Energy. Dermatology. 168(4). 157–162. 72 indexed citations
20.
Filice, G., Valeria Meroni, G Carnevale, P Olliaro, & Giampiero Carosi. (1983). Comparison of ELISA and indirect immunofluorescence in the detection of IgG and IgM antitoxoplasma antibodies.. PubMed. 62(5). 445–50. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. N. MSHANA Breakdown of academic impact, for papers by B Rowan-Kelly Breakdown of academic impact, for papers by Timothy J. Holzer Breakdown of academic impact, for papers by Paulo R. Z. Antas Breakdown of academic impact, for papers by B. R. Andersen Breakdown of academic impact, for papers by G. Tovey Breakdown of academic impact, for papers by Valerie J. F. Quesniaux Breakdown of academic impact, for papers by Parvapan Bhattarakosol Breakdown of academic impact, for papers by HN Madhavan Breakdown of academic impact, for papers by Masao Okumoto
Rankless by CCL
2026